Explaination of New Guideline for Post-approval Changes to Chemical Drug in Combination with the Post-approval Change Managements in China, the United States and Europe

被引：0
|
作者：
Zhang, Baomei [1 ]
Lu, Xiaojun [1 ]
机构：
[1] Center for Drug Evaluation, National Medical Products Administration, Beijing,100022, China
来源：
Chinese Journal of Pharmaceuticals | 2022年 / 53卷 / 07期
关键词：
D O I：
10.16522/j.cnki.cjph.2022.07.020
中图分类号：
学科分类号：
摘要：
7
引用
收藏
页码：1056 / 1061
相关论文
共 50 条
  • [1] Post-Approval Drug Safety Surveillance
    Gibbons, Robert D.
    Amatya, Anup K.
    Brown, C. Hendricks
    Hur, Kwan
    Marcus, Sue M.
    Bhaumik, Dulal K.
    Mann, J. John
    ANNUAL REVIEW OF PUBLIC HEALTH, VOL 31, 2010, 31 : 419 - 437
  • [2] Post-approval drug research: Objectives and methods
    Schafer, H
    PHARMACOPSYCHIATRY, 1997, 30 : 4 - 8
  • [3] Analysis of Typical Problems of Moderate Change in Post-approval Chemical Drugs
    Yuan, Jianlong
    Zhang, Lingna
    Chen, Qingyu
    Huang, Rongzhen
    Chinese Journal of Pharmaceuticals, 2023, 54 (10) : 1517 - 1520
  • [4] More Predictable Post-Approval Change Policy on Horizon
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2019, 32 (09) : 8 - 10
  • [5] More predictable post-approval change policy on Horizon
    Wechsler, Jill
    Pharmaceutical Technology, 2019, 43 (09) : 14 - 15
  • [6] Early utilization pattern of palbociclib 1 year post-approval in the United States
    Kish, J. K.
    Ward, M. A.
    Garofalo, D.
    Ahmed, H. V.
    McRoy, L.
    Laney, J.
    Zanotti, G.
    Yu, H-T
    Feinberg, B. A.
    CANCER RESEARCH, 2017, 77
  • [7] Post-approval safety issues not related to level of drug innovation
    Reactions Weekly, 2013, 1474 (1) : 3 - 3
  • [8] Benefit, burden, and impact for a cohort of post-approval cancer combination trials
    Carlisle, Benjamin Gregory
    Doussau, Adelaide
    Kimmelman, Jonathan
    CLINICAL TRIALS, 2020, 17 (01) : 18 - 29
  • [9] A Global Industry Survey on Post-Approval Change Management and Use of Reliance
    Deavin, Andrew
    Hossain, Aliyah
    Colmagne-Poulard, Isabelle
    Wong, Kum Cheun
    Perea-Velez, Monica
    Cappellini, Sonia
    Ausborn, Susanne
    Meillerais, Sylvie
    Bourguignon, Celine
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (06) : 1094 - 1107
  • [10] DESIGN INNOVATION FOR EFFICIENT POST-APPROVAL DRUG UTILIZATION AND EFFECTIVENESS STUDIES
    Saragoussi, D.
    Rouleau, A.
    Capart, P.
    Deveras, C. C.
    Brett, N.
    Ognar, R.
    Gazay, H.
    Payne, K.
    VALUE IN HEALTH, 2020, 23 : S456 - S456
12345